Intrinsic Therapeutics, Inc.

Intrinsic Therapeutics, Inc. is a medical device company focused on developing advanced technologies to improve the treatment of spine-related disorders. The company is dedicated to offering innovative solutions for patients suffering from degenerative disc disease, aiming to provide a safer and more effective approach compared to traditional methods. Intrinsic Therapeutics' flagship product, the Barricaid® Annular Closure Device, is designed to help support long-term disc health and reduce the risk of reherniation after discectomy surgery. By addressing the underlying cause of disc herniation, Intrinsic Therapeutics aims to help patients regain their active lives with less pain and fewer complications.